Synairgen plc – LSE:SNG.L

Founder-led company

Synairgen stock price today

GBP 208
+205.51
+8253.41%
Financial Health
0
1
2
3
4
5
6
7
8
9

Synairgen stock price monthly change

-48.77%
month

Synairgen stock price quarterly change

-48.77%
quarter

Synairgen stock price yearly change

-59.64%
year

Synairgen key metrics

Market Cap
 4.92M
Enterprise value
 N/A
P/E
 -0.63
EV/Sales
 N/A
EV/EBITDA
 N/A
Price/Sales
 398.42
Price/Book
 0.41
PEG ratio
 N/A
EPS
 -0.12
Revenue
 N/A
EBITDA
 -16.46M
Income
 -13.65M
Revenue Q/Q
 N/A
Revenue Y/Y
 N/A
Profit margin
 -14243.81%
Oper. margin
 -17698.1%
Gross margin
 0%
EBIT margin
 -17698.1%
EBITDA margin
 N/A

Get more financial ratios!

  • Every financial ratio you might need

  • 10 years history

  • Forward ratios (Analysts estimates)

Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Synairgen stock price history

Synairgen stock forecast

Synairgen financial statements

Profit Margin

Synairgen plc (LSE:SNG.L): Profit margin
Jun 2022 0 -12.40K
Dec 2022 0 -5.23M
Jun 2023 0 -4.74M
Dec 2023 0 -3.66M
SNG.L income statement history

Synairgen Financials Estimate

Synairgen plc (LSE:SNG.L): Analyst Estimates
2025 0 -3.00M

  • Analysts Price target

  • Financials & Ratios estimates

Show more

Debt to Assets

Synairgen plc (LSE:SNG.L): Debt to assets
Jun 2022 29544000 4.62M 15.66%
Dec 2022 23529000 3.25M 13.83%
Jun 2023 18706000 2.74M 14.66%
Dec 2023 14221000 1.56M 11%
SNG.L balance sheet history

Cash Flow

Synairgen plc (LSE:SNG.L): Cash Flow
Jun 2022 -15.82K 15 1
Dec 2022 1.65M -3.75M 0
Jun 2023 -4.99M -305K 0
Dec 2023 -2.58M 2.47M 0
SNG.L cash flow history

Synairgen alternative data

Synairgen
Employees

Synairgen plc (LSE:SNG.L): Employee count
Aug 2023 30
Sep 2023 30
Oct 2023 30
Nov 2023 30
Dec 2023 30
Jan 2024 30
Feb 2024 30
Mar 2024 34
Apr 2024 34
May 2024 34
Jun 2024 34
Jul 2024 36

Synairgen other data

Synairgen
Executives

Insider Compensation
Mr. Richard Marsden (1968) Chief Executive Officer, MD & Executive Director
 $415,000
Mr. John Ward (1962) Chief Financial Officer & Executive Director $324,000
Dr. Phillip David Monk (1969) Chairman of Scientific Advisory Board, Chief Scientific Officer & Executive Director
 $302,000
Prof. Stephen T. Holgate CBE, M.D. (1948) Co-Founder, Non-Executive Director & Member of Scientific Advisory Board
 $25,000

Frequently Asked Questions (FAQ)

  • What's the price of Synairgen stock today?

    One share of Synairgen stock can currently be purchased for approximately $208.

  • When is Synairgen's next earnings date?

    Unfortunately, Synairgen's (SNG.L) next earnings date is currently unknown.

  • Does Synairgen pay dividends?

    No, Synairgen does not pay dividends.

  • How much money does Synairgen make?

    Synairgen has a market capitalization of 4.92M.

  • What is Synairgen's stock symbol?

    Synairgen plc is traded on the LSE under the ticker symbol "SNG.L".

  • What is Synairgen's primary industry?

    Company operates in the Healthcare sector and Biotechnology industry.

  • How do i buy shares of Synairgen?

    Shares of Synairgen can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • Who are Synairgen's key executives?

    Synairgen's management team includes the following people:

    • Mr. Richard Marsden Chief Executive Officer, MD & Executive Director(age: 57, pay: $415,000)
    • Mr. John Ward Chief Financial Officer & Executive Director(age: 63, pay: $324,000)
    • Dr. Phillip David Monk Chairman of Scientific Advisory Board, Chief Scientific Officer & Executive Director(age: 56, pay: $302,000)
    • Prof. Stephen T. Holgate CBE, M.D. Co-Founder, Non-Executive Director & Member of Scientific Advisory Board(age: 77, pay: $25,000)

  • Is Synairgen founder-led company?

    Yes, Synairgen is a company led by its founder Prof. Stephen T. Holgate CBE, M.D..

  • How many employees does Synairgen have?

    As Jul 2024, Synairgen employs 36 workers, which is 6% more then previous month and 6% more then previous quarter.

  • When Synairgen went public?

    Synairgen plc is publicly traded company for more then 20 years since IPO on 26 Oct 2004.

  • What is Synairgen's official website?

    The official website for Synairgen is synairgen.com.

  • How can i contact Synairgen?

    Synairgen can be reached via phone at +44 23 8051 2800.

Synairgen company profile:

Synairgen plc

synairgen.com
Exchange:

LSE

Full time employees:

36

Industry:

Biotechnology

Sector:

Healthcare

Synairgen plc discovers and develops drugs for respiratory diseases. It develops SNG001, an inhaled interferon beta for the treatment of COVID-19; inhaled interferon beta (IFN-ß), which is in Phase-II clinical trials for the treatment of asthma caused by the common cold and flu; IFN-ß that is in Phase-II clinical trials for the treatment or prevention of chronic obstructive pulmonary disease; and LOXL2 inhibitor for the treatment of idiopathic pulmonary fibrosis (IPF) disease. The company has a licensing and collaboration agreement with Pharmaxis Ltd. to develop a LOXL2 inhibitor. Synairgen plc was incorporated in 2004 and is headquartered in Southampton, the United Kingdom.

+44 23 8051 2800
Mailpoint 810
Southampton, SO16 6YD

:
ISIN: GB00B0381Z20
: